{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:15:48Z","timestamp":1767838548393,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Adult-onset Still Disease (AoSD) is a rare disorder without standardized diagnostic criteria. People are paying more and more attention to its research. At present, no published studies have assessed the AoSD field using bibliometric tools. This study aimed to analyze research hotspots and frontiers through bibliometrics to provide a scientific and accurate reference for new and existing researchers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were obtained from the Web of Science core database and analyzed by CiteSpace, VOSviewer, and Microsoft Excel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Involving 86 countries and regions, a total of 11,121 authors published 2,199 articles in 676 journals. These studies were published from 1976 to 2020. The United States published the most related articles (397). The United States, France, Italy, and Germany were the top four countries with a high H-index. Authors and institutions with high number of published articles and high citations are mainly located in France and Italy. High-frequency keywords include classification, criteria, diagnosis, and therapy method. Keyword clustering covers the connection between AoSD and rheumatoid arthritis, disease diagnosis, classification, and risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The research on AoSD focuses on the diagnosis and differential diagnosis of the disease. Targeted therapy will become a research hotspot in the future, and relevant clinical research needs to appropriately expand the sample size and improve the credibility of the conclusions. The data reported in this study can serve as a useful resource for researchers studying AoSD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.884780","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T06:25:47Z","timestamp":1655274347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Bibliometrics and Visual Analysis of Adult-onset Still Disease (1976\u20132020)"],"prefix":"10.3389","volume":"10","author":[{"given":"Bowen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binghao","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/art.1780241203","article-title":"HLA-Bw35 and prognosis in adult Still's disease","volume":"24","author":"Terkeltaub","year":"1981","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset Still's disease. Disease course and HLA associations","volume":"29","author":"Wouters","year":"1986","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology"},{"key":"B7","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3899\/jrheum.090316","article-title":"Functional association of interleukin 18 gene-607 (C\/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease","volume":"36","author":"Chen","year":"2009","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4239","article-title":"A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease","volume":"15","author":"Wang","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13394","DOI":"10.1097\/MD.0000000000013394","article-title":"Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease","volume":"97","author":"Yashiro","year":"2018","journal-title":"Medicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3899\/jrheum.161354","article-title":"Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset Still disease","volume":"44","author":"Hsieh","year":"2017","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"B18","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"B19","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","article-title":"Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: a meta-analysis","volume":"28","author":"Ma","year":"2018","journal-title":"Mod Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/03008200903461462","article-title":"The associations of circulating CD4+CD25high regulatory T cells and TGF-\u03b2 with disease activity and clinical course in patients with adult-onset Still's disease","volume":"51","author":"Chen","year":"2010","journal-title":"Connect Tissue Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"690392","DOI":"10.3389\/fphar.2021.690392","article-title":"Bibliometric and visual analysis of vascular calcification research","volume":"12","author":"Dong","year":"2021","journal-title":"Front Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B25","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaci.2016.01.051","article-title":"Primary immune deficiency treatment consortium (PIDTC) update","volume":"138","author":"Griffith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B28","first-page":"107","article-title":"Adult-onset Still's disease","volume":"13","author":"Strumpf","year":"1976","journal-title":"Am Fam Physician"},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOH.0b013e3282f2bcce","article-title":"Chediak-Higashi syndrome","volume":"15","author":"Kaplan","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","article-title":"Chronic granulomatous disease: a comprehensive review","volume":"61","author":"Yu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3899\/jrheum.100766","article-title":"Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population","volume":"38","author":"Jiang","year":"2011","journal-title":"J Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1517\/13543784.17.3.349","article-title":"The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis","volume":"17","author":"Kalliolias","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still's disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still's disease-the evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive article review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ncprheum0510","article-title":"Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?","volume":"3","author":"Efthimiou","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","article-title":"Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies","volume":"51","author":"Efthimiou","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-019-08747-8","article-title":"Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease","volume":"58","author":"Li","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/TCRM.S155488","article-title":"Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review","volume":"14","author":"Zhou","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1759720X211059598","DOI":"10.1177\/1759720X211059598","article-title":"Update on the therapy of adult-onset Still's disease with a focus on IL-1-inhibition: a systematic review","volume":"13","author":"Kedor","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.18520\/cs\/v116\/i11\/1909-1914","article-title":"Comparison between scopus, web of science, pubmed and publishers for mislabelled review papers","volume":"116","author":"Yeung","year":"2019","journal-title":"Curr Sci"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.884780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T06:25:58Z","timestamp":1655274358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.884780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":44,"alternative-id":["10.3389\/fpubh.2022.884780"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.884780","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"article-number":"884780"}}